Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

S. Kasar, J. Kim, R. Improgo, G. Tiao, P. Polak, N. Haradhvala, M. S. Lawrence, A. Kiezun, S. M. Fernandes, S. Bahl, C. Sougnez, S. Gabriel, E. S. Lander, H. T. Kim, G. Getz () and J. R. Brown ()
Additional contact information
S. Kasar: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School
J. Kim: Cancer Program, Broad Institute of Harvard and MIT
R. Improgo: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School
G. Tiao: Cancer Program, Broad Institute of Harvard and MIT
P. Polak: Cancer Program, Broad Institute of Harvard and MIT
N. Haradhvala: Cancer Program, Broad Institute of Harvard and MIT
M. S. Lawrence: Cancer Program, Broad Institute of Harvard and MIT
A. Kiezun: Cancer Program, Broad Institute of Harvard and MIT
S. M. Fernandes: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School
S. Bahl: Cancer Program, Broad Institute of Harvard and MIT
C. Sougnez: Cancer Program, Broad Institute of Harvard and MIT
S. Gabriel: Cancer Program, Broad Institute of Harvard and MIT
E. S. Lander: Cancer Program, Broad Institute of Harvard and MIT
H. T. Kim: Dana-Farber Cancer Institute
G. Getz: Cancer Program, Broad Institute of Harvard and MIT
J. R. Brown: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School

Nature Communications, 2015, vol. 6, issue 1, 1-12

Abstract: Abstract Patients with chromosome 13q deletion or normal cytogenetics represent the majority of chronic lymphocytic leukaemia (CLL) cases, yet have relatively few driver mutations. To better understand their genomic landscape, here we perform whole-genome sequencing on a cohort of patients enriched with these cytogenetic characteristics. Mutations in known CLL drivers are seen in only 33% of this cohort, and associated with normal cytogenetics and unmutated IGHV. The most commonly mutated gene in our cohort, IGLL5, shows a mutational pattern suggestive of activation-induced cytidine deaminase (AID) activity. Unsupervised analysis of mutational signatures demonstrates the activities of canonical AID (c-AID), leading to clustered mutations near active transcriptional start sites; non-canonical AID (nc-AID), leading to genome-wide non-clustered mutations, and an ageing signature responsible for most mutations. Using mutation clonality to infer time of onset, we find that while ageing and c-AID activities are ongoing, nc-AID-associated mutations likely occur earlier in tumour evolution.

Date: 2015
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/ncomms9866 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9866

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms9866

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().